documents: FDA-2023-N-3392-0040
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2023-N-3392-0040 | FDA | FDA-2023-N-3392 | Reference 38 - FDA, “Classification of Products as Drugs and Devices & Additional Product Classification Issues: Guidance for Industry and FDA Staff,” September 2017 | Supporting & Related Material | Background Material | 2023-12-07T05:00:00Z | 2023 | 12 | 2023-12-07T23:14:36Z | 0 | 0 | 090000648630cc31 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref